Cargando…
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020
BACKGROUND: Subgroup analyses of randomized controlled trials are very common in oncology; nevertheless, the methodological approach has not been systematically evaluated. The present analysis was conducted with the aim of describing the prevalence and methodological characteristics of the subgroup...
Autores principales: | Paratore, C., Zichi, C., Audisio, M., Bungaro, M., Caglio, A., Di Liello, R., Gamba, T., Gargiulo, P., Mariniello, A., Reale, M.L., Perrone, F., Di Maio, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808470/ https://www.ncbi.nlm.nih.gov/pubmed/36228332 http://dx.doi.org/10.1016/j.esmoop.2022.100593 |
Ejemplares similares
-
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
por: Aimar, Giacomo, et al.
Publicado: (2021) -
Second-line treatment options in hepatocellular carcinoma
por: Marino, Donatella, et al.
Publicado: (2019) -
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
por: Di Liello, Raimondo, et al.
Publicado: (2021) -
Local for advanced, is this a paradox?
por: Bungaro, Maristella, et al.
Publicado: (2021) -
MA12.07 Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center
por: Bungaro, M., et al.
Publicado: (2021)